Related Experiment Video
Updated: Aug 9, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign
J A Van Amburgh1, N M Waite, E H Hobson
1From School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, USA.
Study Objective:
To increase the rate of influenza vaccinations in high-risk patients by means of a pharmacist-managed immunization campaign.
Design:
Unblinded, single intervention.
Setting:
Rural primary care clinic.
Patients:
Six hundred fifty-seven patients at high risk for contracting influenza according to criteria established by the Centers for Disease Control and Prevention.
Intervention:
High-risk patients identified by chart review were mailed an education packet on influenza immunization. Vaccinations were given in specially designated clinics and during routine clinic visits. Campaign success and reasons why patients remained unvaccinated were determined by follow-up surveys.
Measurements And Main Results:
The influenza vaccination rate increased from 28% at baseline (before program initiation) to 54% after program initiation. Unvaccinated patients were younger and resided in more urban areas than vaccinated patients; vaccinated patients had a higher frequency of cardiovascular disease or diabetes mellitus. Vaccinated patients consistently identified the education packet and their health care providers as primary motivators for vaccination.
Conclusion:
Our pharmacist-managed vaccine program increased the influenza immunization rate in high-risk patients.
Related Concept Videos
Vaccinations
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

